These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8911012)

  • 1. Oral application of romurtide, a synthetic muramyl dipeptide derivative, stimulates nonspecific resistance to microbial infections and hematopoiesis in mice.
    Namba K; Nakajima R; Otani T; Azuma I
    Vaccine; 1996 Aug; 14(12):1149-53. PubMed ID: 8911012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of host defense mechanism against infection by a cytokine inducer, an acyl-MDP derivative, MDP-Lys(L18) (romurtide) in mice and humans.
    Azuma I; Otani T
    Med Res Rev; 1994 Jul; 14(4):401-14. PubMed ID: 8084203
    [No Abstract]   [Full Text] [Related]  

  • 3. Romurtide, a synthetic muramyl dipeptide derivative, accelerates peripheral platelet recovery in nonhuman primate chemotherapy model.
    Namba K; Nitanai H; Otani T; Azuma I
    Vaccine; 1996 Oct; 14(14):1322-6. PubMed ID: 9004440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tumor necrosis factor-alpha in solid tumor region by the orally administered synthetic muramyl dipeptide analogue, romurtide.
    Ueda H; Yamazaki M
    Int Immunopharmacol; 2001 Jan; 1(1):97-104. PubMed ID: 11367521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Romurtide, a synthetic muramyl dipeptide derivative, promotes megakaryocytopoiesis through stimulation of cytokine production in nonhuman primates with myelosuppression.
    Namba K; Yamamura E; Nitanai H; Otani T; Azuma I
    Vaccine; 1997 Mar; 15(4):405-13. PubMed ID: 9141212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory effect of romurtide on hematopoiesis in monkeys.
    Nakajima R; Yshida Y; Akahane K; Sekiguchi M; Osada Y
    Arzneimittelforschung; 1991 Jan; 41(1):60-5. PubMed ID: 2049113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: inducer of cytokines in vivo: overview of field and romurtide experience.
    Azuma I
    Int J Immunopharmacol; 1992 Apr; 14(3):487-96. PubMed ID: 1618600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of romurtide with ampicillin against pneumococcal pneumonia in mice.
    Nakajima R; Namba K; Ishida Y; Katsuma E; Otani T; Osada Y
    Chemotherapy; 1992; 38(4):238-50. PubMed ID: 1473363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
    Osada Y; Mitsuyama M; Une T; Matsumoto K; Otani T; Satoh M; Ogawa H; Nomoto K
    Infect Immun; 1982 Jul; 37(1):292-300. PubMed ID: 6809630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation.
    Galelli A; Chedid L
    Infect Immun; 1983 Dec; 42(3):1081-5. PubMed ID: 6605930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of anomeric pairs of lipophilic glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Kalyuzhin OV; Zemlyakov AE; Kalina NG; Mulik EL; Kuzovlev FN; Makarova OV
    Bull Exp Biol Med; 2008 May; 145(5):623-5. PubMed ID: 19145298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of platelet recovery in X-irradiated guinea pigs by romurtide, a synthetic muramyl dipeptide derivative.
    Namba K; Otani T; Osada Y
    Blood; 1994 May; 83(9):2480-8. PubMed ID: 8167336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic and prophylactic effects of romurtide against experimental animal infections.
    Niki Y; Tatara O
    Adv Exp Med Biol; 1992; 319():185-91. PubMed ID: 1414593
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of MDP-Lys(L18) as a mucosal immunoadjuvant on protection of mucosal infections by Sendai virus and rotavirus.
    Fukushima A; Yoo YC; Yoshimatsu K; Matsuzawa K; Tamura M; Tono-oka S; Taniguchi K; Urasawa S; Arikawa J; Azuma I
    Vaccine; 1996 Apr; 14(6):485-91. PubMed ID: 8782344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An increase in the immunogenicity of bacterial antigens under the influence of one of the derivatives of muramyl dipeptide].
    Britsina MV; Shepeleva IB; Baturo AP; Elkina SI; Kalina NG; Andronova TM; Ermolova EV; Zakharova NS; Ivanov VT; Sokolova TV
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):43-5. PubMed ID: 1455969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
    Yamaguchi F; Akasaki M; Tsukada W
    Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increase of non-specific resistance to infection by synthetic adjuvants].
    Parant M; Chedid L
    C R Seances Soc Biol Fil; 1979; 173(2):201-12. PubMed ID: 159749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of MDP-Lys(L18), a derivative of MDP, on enhancing host resistance against Hantaan virus infection in newborn mice.
    Yoo YC; Yoshimatsu K; Hatsuse R; Tamura M; Yoshida R; Tono-oka S; Arikawa J; Azuma I
    Vaccine; 1995 Oct; 13(14):1300-5. PubMed ID: 8585284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulation of the nonspecific resistance by beta-heptylglycoside-muramyldipeptide in mice].
    Kaliuzhin OV; Kaliuzhin VV; Zemliakov AE; Elkina SI; Shkalev MV; Sergeev VV
    Biull Eksp Biol Med; 1999 May; 127(5):543-5. PubMed ID: 10399577
    [No Abstract]   [Full Text] [Related]  

  • 20. Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.
    Osada Y; Mitsuyama M; Matsumoto K; Une T; Otani T; Ogawa H; Nomoto K
    Infect Immun; 1982 Sep; 37(3):1285-8. PubMed ID: 6752024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.